Cargando…

Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy

BACKGROUND: This study aimed to investigate radiation-induced lymphopenia and its potential risk factors in patients with breast cancer receiving adjuvant radiotherapy. METHODS: Breast cancer patients received adjuvant radiotherapy (RT) at our hospital with peripheral lymphocyte counts (PLC) at pre-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fang, Yu, Hao, Zhang, Hong, Nong, Yaqing, Wang, Qian, Jing, Haiman, Han, Ying, Wu, Junjie, Zhou, Zheng, Yang, Li, Xu, Zhiyuan, Liu, Yaya, Fu, Pingfu, Jin, Jian-Yue, Hsue, Victor, Chang, Amy, Kong, Feng-Ming (Spring)
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422134/ https://www.ncbi.nlm.nih.gov/pubmed/34532425 http://dx.doi.org/10.21037/atm-21-2150

Ejemplares similares

Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer
por: Chen, Fang, et al.
Publicado: (2021)

Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022)

Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022)

Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation
por: Zhang, Jinliang, et al.
Publicado: (2023)

Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer
por: Yang, Li, et al.
Publicado: (2022)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
por: De, Brian, et al.
Publicado: (2021)

Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2020)

Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach
por: Yu, Hao, et al.
Publicado: (2022)

Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
por: Liu, Jing, et al.
Publicado: (2017)

Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
por: Byun, Hwa Kyung, et al.
Publicado: (2019)

A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
por: Wang, Xin, et al.
Publicado: (2020)

Severe lymphopenia as a prognostic factor in rectal cancer patients receiving adjuvant chemoradiotherapy: a retrospective study
por: Li, Shuang, et al.
Publicado: (2023)

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors
por: Qian, Jack M., et al.
Publicado: (2021)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
por: Sheu, Ting-Ting, et al.
Publicado: (2021)

A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer
por: Xu, Zhiyuan, et al.
Publicado: (2022)

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
por: Iorio, Giuseppe Carlo, et al.
Publicado: (2020)

Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer
por: Sakaguchi, Masakuni, et al.
Publicado: (2021)

Lymphopenia in SARS
por: Panesar, Nirmal S
Publicado: (2003)

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
por: Ebrahimi, Saba, et al.
Publicado: (2021)

Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer
por: Lee, Shing Fung, et al.
Publicado: (2022)

Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
por: Yoon, Chang Ik, et al.
Publicado: (2023)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer
por: Schad, Michael D., et al.
Publicado: (2019)

Chronic Morbidity in Patients with Endometrial Cancer who Received Adjuvant Radiotherapy
por: Cid Sánchez, Dharely Raquel, et al.
Publicado: (2019)

Lymphopenia and autoimmune diseases
por: Schulze-Koops, Hendrik
Publicado: (2004)

The Impact of Lymphopenia on Delirium in ICU Patients
por: Inoue, Shigeaki, et al.
Publicado: (2015)

Dosimetry of the brain and hypothalamus predicting acute lymphopenia and the survival of glioma patients with postoperative radiotherapy
por: Ye, Lu‐Lu, et al.
Publicado: (2019)

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy
por: Cheng, Xingyuan, et al.
Publicado: (2023)

The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy
por: Liu, Ming, et al.
Publicado: (2021)

Fever, splenomegaly and lymphopenia in sarcoidosis
por: Ravaglia, Claudia, et al.
Publicado: (2013)

Cladribine: Lymphopenia: case report
Publicado: (2021)

Lymphopenia and Mechanisms of T-Cell Regeneration
por: Saidakova, E. V.
Publicado: (2022)

Lymphopenia in Esophageal Cancer: What Have We Learned?
por: Wang, Jia-Lin, et al.
Publicado: (2021)

Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model
por: Telarovic, Irma, et al.
Publicado: (2022)

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC
por: Jing, Wang, et al.
Publicado: (2022)

Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: model development and validation
por: Yu, Yishan, et al.
Publicado: (2020)

Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study
por: Ju, Wutong, et al.
Publicado: (2023)

Lesion Site Is the Key Prognostic Factor for Keloid Patients Receiving Surgery With Adjuvant Radiotherapy
por: Chen, Frank, et al.
Publicado: (2022)

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma
por: Crocenzi, Todd, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7bc6uj1otprkod5doonll6ohsd